These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

706 related items for PubMed ID: 18682947

  • 1. The 19-bp deletion of dihydrofolate reductase (DHFR), methylenetetrahydrofolate reductase (MTHFR) C677T, Factor V Leiden, prothrombin G20210A polymorphisms in cancer patients with and without thrombosis.
    Eroglu A, Egin Y, Cam R, Akar N.
    Ann Hematol; 2009 Jan; 88(1):73-6. PubMed ID: 18682947
    [Abstract] [Full Text] [Related]

  • 2. The frequency of factor V Leiden and concomitance of factor V Leiden with prothrombin G20210A mutation and methylene tetrahydrofolate reductase C677T gene mutation in healthy population of Denizli, Aegean region of Turkey.
    Kabukcu S, Keskin N, Keskin A, Atalay E.
    Clin Appl Thromb Hemost; 2007 Apr; 13(2):166-71. PubMed ID: 17456626
    [Abstract] [Full Text] [Related]

  • 3. Impact of thrombophilic genes mutations on thrombosis risk in Egyptian nonmetastatic cancer patients.
    Wahba MA, Ismail MA, Saad AA, Habashy DM, Hafeez ZM, Boshnak NH.
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):309-15. PubMed ID: 25565385
    [Abstract] [Full Text] [Related]

  • 4. Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients.
    Yasa MH, Bolaman Z, Yukselen V, Kadikoylu G, Karaoglul AO, Batun S.
    Hepatogastroenterology; 2007 Apr; 54(77):1438-42. PubMed ID: 17708272
    [Abstract] [Full Text] [Related]

  • 5. Factor V G1691A, prothrombin G20210A and methylenetetrahydrofolate reductase polymorphism C677T are not associated with coronary artery disease and type 2 diabetes mellitus in western Iran.
    Rahimi Z, Nomani H, Mozafari H, Vaisi-Raygani A, Madani H, Malek-Khosravi S, Parsian A.
    Blood Coagul Fibrinolysis; 2009 Jun; 20(4):252-6. PubMed ID: 19349859
    [Abstract] [Full Text] [Related]

  • 6. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.
    Mueller T, Marschon R, Dieplinger B, Haidinger D, Gegenhuber A, Poelz W, Webersinke G, Haltmayer M.
    J Vasc Surg; 2005 May; 41(5):808-15. PubMed ID: 15886665
    [Abstract] [Full Text] [Related]

  • 7. Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients.
    Dölek B, Eraslan S, Eroğlu S, Kesim BE, Ulutin T, Yalçiner A, Laleli YR, Gözükirmizi N.
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):435-8. PubMed ID: 17911197
    [Abstract] [Full Text] [Related]

  • 8. Analysis of prothrombotic mutations and polymorphisms in children who developed thrombosis in the perioperative period of congenital cardiac surgery.
    Ozbek N, Ataç FB, Yildirim SV, Verdi H, Yazici C, Yilmaz BT, Tokel NK.
    Cardiol Young; 2005 Feb; 15(1):19-25. PubMed ID: 15831156
    [Abstract] [Full Text] [Related]

  • 9. The platelet glycoprotein Ia/IIa gene polymorphism C807T/G873A: a novel risk factor for retinal vein occlusion.
    Dodson PM, Haynes J, Starczynski J, Farmer J, Shigdar S, Fegan G, Johnson RJ, Fegan C.
    Eye (Lond); 2003 Aug; 17(6):772-7. PubMed ID: 12928694
    [Abstract] [Full Text] [Related]

  • 10. Prevalence of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations in 200 healthy Jordanians.
    Eid SS, Rihani G.
    Clin Lab Sci; 2004 Aug; 17(4):200-2. PubMed ID: 15559724
    [Abstract] [Full Text] [Related]

  • 11. The prevalence of factor V (G1691A), MTHFR (C677T) and PT (G20210A) gene mutations in arterial thrombosis.
    Ozmen F, Ozmen MM, Ozalp N, Akar N.
    Ulus Travma Acil Cerrahi Derg; 2009 Mar; 15(2):113-9. PubMed ID: 19353312
    [Abstract] [Full Text] [Related]

  • 12. Prevalence of prothrombin G20210A, factor V G1691A (Leiden), and methylenetetrahydrofolate reductase (MTHFR) C677T in seven different populations determined by multiplex allele-specific PCR.
    Hessner MJ, Luhm RA, Pearson SL, Endean DJ, Friedman KD, Montgomery RR.
    Thromb Haemost; 1999 May; 81(5):733-8. PubMed ID: 10365746
    [Abstract] [Full Text] [Related]

  • 13. Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease.
    Toydemir PB, Elhan AH, Tükün A, Toydemir R, Gürler A, Tüzüner A, Bökesoy I.
    J Rheumatol; 2000 Dec; 27(12):2849-54. PubMed ID: 11128675
    [Abstract] [Full Text] [Related]

  • 14. Factor V Leiden, prothrombin G20210A and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms and the risk of tamoxifen-associated thromboembolism in breast cancer patients.
    Eroğlu A, Akar N.
    Thromb Res; 2011 Apr; 127(4):384-5. PubMed ID: 21093891
    [No Abstract] [Full Text] [Related]

  • 15. [C677T mutation in methylentetrahydrofolatereductase gene in patients with venous thromboses from the central region of Russia correlates with a high risk of pulmonary artery thromboembolism].
    Avdonin PV, Kirienko AI, Kozhevnikova LM, Shostak NA, Babadaeva NM, Leont'ev SG, Petukhov EB, Kubatiev AA, Savel'ev VS.
    Ter Arkh; 2006 Apr; 78(6):70-6. PubMed ID: 16881367
    [Abstract] [Full Text] [Related]

  • 16. Risk of recurrent venous thrombosis in patients with G20210A mutation in the prothrombin gene or factor V Leiden mutation.
    González-Porras JR, García-Sanz R, Alberca I, López ML, Balanzategui A, Gutierrez O, Lozano F, San Miguel J.
    Blood Coagul Fibrinolysis; 2006 Jan; 17(1):23-8. PubMed ID: 16607075
    [Abstract] [Full Text] [Related]

  • 17. Association between factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations and events of the arterial circulatory system: a meta-analysis of published studies.
    Kim RJ, Becker RC.
    Am Heart J; 2003 Dec; 146(6):948-57. PubMed ID: 14660985
    [Abstract] [Full Text] [Related]

  • 18. Primer-engineered multiplex PCR-RFLP for detection of MTHFR C677T, prothrombin G20210A and factor V Leiden mutations.
    Koksal V, Baris I, Etlik O.
    Exp Mol Pathol; 2007 Aug; 83(1):1-3. PubMed ID: 17275807
    [Abstract] [Full Text] [Related]

  • 19. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.
    Nishank SS, Singh MP, Yadav R.
    Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124
    [Abstract] [Full Text] [Related]

  • 20. The prevalence of factor V Leiden (G1691A), prothrombin G20210A and methylenetetrahydrofolate reductase C677T mutations in Jordanian patients with beta-thalassemia major.
    Al-Sweedan SA, Jaradat S, Iraqi M, Beshtawi M.
    Blood Coagul Fibrinolysis; 2009 Dec; 20(8):675-8. PubMed ID: 19710606
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.